Work

Chemo-Immunotherapy with Hyper-CVAD Plus Ritixumab for Adult Burkitt’s and Burkitt’s Type Lymphoma (BL) or Acute Lymphoblastic Leukemia (B-ALL).

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.149.149

Authors: Deborah A. Thomas, Stefan Faderl, Susan O’Brien, Carlos Bueso-Ramos, Jorge Cortes, Guillermo Garcia-Manero, Francis Giles, Srdan Verstovsek, William Wierda, Sherry Pierce, Jiaquin Shan, Mark Brandt, Fredrick Hagemeister, Fernando Cabanillas, Michael J. Keating, Hagop Kantarjian

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598632023

FWCI: 0.665

Cites:

Cited by: 3

Related to: 10